You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The San Diego-based firm anticipates launching an LDT for early-stage lung cancer out of a CLIA-certified, CAP-accredited lab within the next two years.
Researchers used sequence data from variola virus strains in 11 "Viking Age" individuals from northern Europe to gain new clues about smallpox evolution.
The firms are developing clinical and RUO workflows that use NGS for pathogen identification and will comarket IDbyDNA's Explify data platform.
The University of Utah spinout said it will use the funding to enhance and expand its NGS-based Explify microbe identification platform and support its lab.
The genomes of four children who died in Cameroon 3,000 to 8,000 years ago pointed to diverse early lineages and helped tease out historical population relationships.
The companies are aiming to use microbial biomarkers to predict the development of precancerous adenomas and carcinomas.
A SUNY Upstate team identified potential PD biomarkers in patients' oral microbiomes, which may lead to a saliva-based assay for early-stage disease.
The investment bank said that PacBio's SMRT sequencing technology has always been attractive compared to traditional NGS shotgun sequencing.
The funding will support the further development of Aperiomics' deep metagenomic shotgun sequencing-based test for identifying infectious disease pathogens.
Researchers profiled the composition and gene content of microbial communities in mouth, gut, and vaginal samples collected from 10 pregnant women.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.